Brief: Satsuma Pharmaceuticals - On Nov 3, Co Entered Into At-The-Market Sales Agreement, Pursuant To Which Co May Offer & Sell Shares Of Co’S Common Stock
03/11/2022 22:38
Nov 3 (Reuters) - Satsuma Pharmaceuticals Inc STSA.O :
* SATSUMA PHARMACEUTICALS - ON NOV 3, CO ENTERED INTO
AT-THE-MARKET SALES AGREEMENT, PURSUANT TO WHICH CO MAY OFFER &
SELL SHARES OF CO’S COMMON STOCK
Further company coverage: STSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Satsuma Pharmaceuticals
See all newsBrief: Satsuma Pharmaceuticals Announces FDA Acceptance Of 505(B)(2) NDA For Sts101, A Novel And Investigational Dihydroergotamine Nasal Powder Product For The Acute Treatment Of Migraine
Commencement Of Tender Offer For Satsuma Pharmaceuticals, Inc In U.S.
Brief: Satsuma Pharmaceuticals Says Received Letter Notifying Co Regained Compliance With Nasdaq
U.S. STOCKS ON THE MOVE-Alphabet Inc, BlackRock, Moderna
Satsuma Pharma soars on buyout deal from Japan's Shin Nippon